The annual CAHR Conference is the premier gathering in Canada for those working in all disciplines of HIV/AIDS research, as well as policy makers, persons living with HIV and other individuals committed to ending the pandemic.

HR17, the 25th Harm Reduction International (HRI) Conference, will be 2017’s largest international harm reduction event. It will bring together those at the heart of the harm reduction response – from practitioners and peers to advocates and researchers – for four packed days of presentations, workshops, panel discussions, films, exhibitions, networking events and more.

First held in Liverpool 27 years ago, HRI conferences have since been staged in major cities across the globe. This year, we’re returning to North America for the first time since our Vancouver conference in 2006. HR17 will be hosted on 14th-17th May 2017 in Montréal, Canada, in partnership with the Association des Intervenants en Dépendance du Québec (AIDQ).

As Canada begins to adopt a more forward-looking approach to drugs, in the rest of the region – and much of the planet – progress is still painfully slow. In response, HR17 will help build a global harm reduction movement that learns, shares and cooperates to build a world where people benefit from good drug policies, rooted in dignity, health and human rights.

Canadian HIV/AIDS Legal Network

This year’s Symposium is devoted to a critical look at the unjust criminalization of HIV non-disclosure. Themes to be discussed include:

• Current state of criminalization: Canada and the world
• Voices rising: speaking out about the experience of HIV criminalization
• Science of HIV transmission: recent applications, emerging issues
• Advocacy updates and ways forward

Details for the 7th Symposium are now being finalized. We will update this page with more details as they become available, including a full list of speakers.

Register here for the Symposium. The following registration fees apply:

• General admission: $75
• Legal Network members: $50
• Students, low-income and persons living with HIV or AIDS: $25*

*Please note that, if necessary, you can request a full waiver of this reduced fee by contacting the Legal Network office.

If you have questions about the Symposium, please contact info@aidslaw.ca.

Coinciding with 23rd International Day of the World’s Indigenous Peoples.

The Second World Indigenous Peoples’ Conference on Viral Hepatitis will provide a platform to profile and further the conversation on viral hepatitis in Indigenous communities.

The conference is led by Indigenous people and is designed for Indigenous peoples, clinicians, those working in Indigenous health and civil society organizations.

RESULTS Canada is hosting a round table discussion at the University of British Columbia on September 29, 2017. If you or those in your network are involved in the Canadian global health R&D sector please consider attending and/or share this across your own network.

We need to hear directly from you on the opportunities, gaps and best practices in your experience concerning global health R&D, particularly for diseases of poverty. According to a recent funding report that maps out Canada’s spending into neglected R&D for diseases of poverty, funding is low, inconsistent, and lacks diversity. Launching from this research, we would like to investigate in greater detail the challenges and opportunities facing the global health R&D community in Canada. We will use this to help inform a set of policy recommendations to move Canada’s R&D funding for global health and diseases of poverty forward. Now is a key time to voice the needs of the research community if we want to see the full potential of the Canadian global health community realized.

RESULTS Canada is a global advocacy organization that works to create the political will to end poverty through focused advocacy in global nutrition, child health, education and tuberculosis. We work with a variety of stakeholders to advance these causes, including elected officials, NGOs, multilateral organizations, federal officials, and members of the Canadian public.